Skip to content
healthcare.dev

Anastrozole

NDC 68001-155, Anastrozole, tablet, coated, from BluePoint Laboratories.

Product NDC
68001-155
Status
Listed
Labeler
BluePoint Laboratories
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078921
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68001-155 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ANASTROZOLE1 mg/1

Pharmacologic classes

Aromatase Inhibitor [EPC]; Aromatase Inhibitors [MoA]

Package NDCNDC-11Package
68001-155-046800101550430 TABLET, COATED in 1 BOTTLE (68001-155-04)
68001-155-08680010155081000 TABLET, COATED in 1 BOTTLE (68001-155-08)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3cd04ed6-7c5a-4c4a-9955-ee40839dfea0
  • NADAC price for package 68001015504

    GET /v1/drugs/nadac/68001015504
  • NADAC price for package 68001015508

    GET /v1/drugs/nadac/68001015508

Use it

Look up 68001-155 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68001-155 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68001-155. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.